Zimmer Biomet Holdings, Inc. (VIE:ZBH)

Zimmer Biomet Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	8,011	7,679	7,394	6,940	6,827	6,128
Revenue Growth (YoY)	5.47%	3.85%	6.55%	1.65%	11.42%	-23.23%
Cost of Revenue	2,273	2,180	2,076	2,020	1,960	1,824
Gross Profit	5,738	5,499	5,319	4,920	4,867	4,303
Selling, General & Admin	3,077	2,876	2,793	2,668	2,626	2,524
Research & Development	448.3	437.4	458.7	406	435.8	322.8
Amortization of Goodwill & Intangibles	645.8	591.9	561.5	526.8	529.5	512.1
Other Operating Expenses	-	-	-	33.8	52.8	50.9
Operating Expenses	4,171	3,905	3,813	3,634	3,645	3,410
Operating Income	1,567	1,594	1,505	1,286	1,222	893
Interest Expense	-282.8	-218	-201.2	-164.8	-208.4	-212.1
Currency Exchange Gain (Loss)	-13.9	-15.6	-17.2	-19.7	-5.5	-12.2
Other Non Operating Income (Expenses)	5.5	3	-0.3	-0.5	1.7	13.7
EBT Excluding Unusual Items	1,276	1,363	1,287	1,101	1,010	682.4
Merger & Restructuring Charges	-109.4	-247	-181.8	-203	-125.7	-107.2
Impairment of Goodwill	-	-	-	-289.8	-	-470
Gain (Loss) on Sale of Investments	-42.1	-42.1	-16	-136	-	-
Legal Settlements	-32.6	-30.5	-21.6	-65.9	-201	-166
Other Unusual Items	-69.9	-7.1	-	-	-168.2	-11.4
Pretax Income	1,022	1,037	1,067	403.5	499	-105.2
Income Tax Expense	214.5	131.4	42.2	112.3	53.5	-96
Earnings From Continuing Operations	807.4	905.3	1,025	291.2	445.5	-9.2
Earnings From Discontinued Operations	-	-	-	-58.8	-43.4	-128.2
Net Income to Company	807.4	905.3	1,025	232.4	402.1	-137.4
Minority Interest in Earnings	-2.1	-1.5	-1.1	-1	-0.5	-1.5
Net Income	805.3	903.8	1,024	231.4	401.6	-138.9
Net Income to Common	805.3	903.8	1,024	231.4	401.6	-138.9
Net Income Growth	-25.68%	-11.74%	342.52%	-42.38%	-	-
Shares Outstanding (Basic)	199	203	209	210	209	207
Shares Outstanding (Diluted)	199	204	210	210	210	207
Shares Change (YoY)	-3.29%	-2.77%	-0.29%	-0.05%	1.64%	0.14%
EPS (Basic)	4.06	4.45	4.91	1.10	1.93	-0.67
EPS (Diluted)	4.03	4.43	4.88	1.10	1.91	-0.67
EPS Growth	-23.28%	-9.22%	343.48%	-42.50%	-	-
Free Cash Flow	1,207	1,055	978.8	838.5	1,082	833.6
Free Cash Flow Per Share	6.06	5.18	4.67	3.99	5.14	4.03
Dividend Per Share	0.960	0.960	0.960	0.960	0.960	0.960
Gross Margin	71.62%	71.61%	71.93%	70.90%	71.29%	70.23%
Operating Margin	19.56%	20.76%	20.36%	18.53%	17.90%	14.57%
Profit Margin	10.05%	11.77%	13.85%	3.33%	5.88%	-2.27%
Free Cash Flow Margin	15.06%	13.74%	13.24%	12.08%	15.85%	13.60%
EBITDA	2,641	2,590	2,457	2,213	2,160	1,791
EBITDA Margin	32.96%	33.73%	33.23%	31.88%	31.64%	29.23%
D&A For EBITDA	1,073	996.3	951.7	926.4	937.7	898.4
EBIT	1,567	1,594	1,505	1,286	1,222	893
EBIT Margin	19.56%	20.76%	20.36%	18.53%	17.90%	14.57%
Effective Tax Rate	20.99%	12.68%	3.95%	27.83%	10.72%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.